ZSWIM2 inhibitors belong to a specialized class of chemical compounds that target and modulate the activity of the ZSWIM2 protein, which is a member of the ZSWIM (Zinc finger SWIM domain-containing) family. These proteins contain a characteristic SWIM domain (SWI2/SNF2 and MuDR domain), a structural motif associated with metal-binding, typically zinc, and involved in protein-protein interactions. The ZSWIM2 protein is implicated in various intracellular processes such as gene regulation, protein degradation, and cellular signaling. It is primarily thought to play a role in modulating ubiquitin pathways, as well as being associated with DNA repair and chromatin remodeling mechanisms, which are vital for maintaining genome integrity. The inhibition of ZSWIM2 offers a strategic approach to study these pathways by altering how the protein participates in molecular complexes that control the ubiquitin-proteasome system and chromatin dynamics.
The design and synthesis of ZSWIM2 inhibitors typically require a deep understanding of the protein's structure and its interaction with other biomolecules. Inhibitors can be small molecules or peptides that interact with the SWIM domain or other crucial regions of ZSWIM2, preventing it from binding to its targets. Such inhibition can affect downstream signaling cascades, making these compounds useful for probing the functional roles of ZSWIM2 in cellular processes such as DNA damage response and protein homeostasis. Structural biology techniques, including X-ray crystallography and NMR spectroscopy, are often used to define the precise binding sites of inhibitors, while computational modeling helps in refining their structure to improve selectivity and efficacy. These chemical tools are critical for basic research aimed at understanding the mechanistic roles of ZSWIM2 and its associated pathways, shedding light on the fundamental biology that governs cellular homeostasis and genomic stability.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, which is a part of the PI3K/Akt signaling pathway, potentially reducing ZSWIM2 activity linked to this pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, which may reduce ZSWIM2 function indirectly by interfering with the MAPK/ERK pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, potentially altering cellular responses that could intersect with ZSWIM2 activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, which could attenuate cellular processes that are regulated by ZSWIM2 through stress response pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, which may affect ZSWIM2's role in growth control and autophagy, if any. | ||||||
Wnt-C59 | 1243243-89-1 | sc-475634 sc-475634A sc-475634B | 5 mg 10 mg 50 mg | $214.00 $326.00 $1275.00 | 1 | |
Inhibits Wnt production, potentially affecting ZSWIM2 activity by altering Wnt signaling pathways. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
Inhibits γ-secretase, which may affect ZSWIM2 function by impacting Notch signaling pathways. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitor that may disrupt protein degradation pathways, indirectly affecting ZSWIM2's regulatory roles, if any. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
Inhibits Smoothened, a component of the Hedgehog signaling pathway, potentially impacting ZSWIM2 activity through this pathway. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Inhibits MEK1/2, potentially reducing ZSWIM2's activity through indirect effects on the MAPK/ERK pathway. | ||||||